Bruker Corp BRKR

Morningstar Rating
$67.00 +1.20 (1.82%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BRKR is trading at a 343% premium.
Price
$65.69
Fair Value
$51.45
Uncertainty
High
1-Star Price
$23.51
5-Star Price
$54.55
Economic Moat
Gtzjc
Capital Allocation

News

Trading Information

Previous Close Price
$65.80
Day Range
$66.0467.42
52-Week Range
$53.7994.86
Bid/Ask
$66.44 / $67.41
Market Cap
$10.14 Bil
Volume/Avg
671,155 / 1.1 Mil

Key Statistics

Price/Earnings (Normalized)
26.43
Price/Sales
3.10
Dividend Yield (Trailing)
0.30%
Dividend Yield (Forward)
0.30%
Total Yield
0.30%

Company Profile

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
9,707

Comparables

Valuation

Metric
BRKR
301122
688468
Price/Earnings (Normalized)
26.4331.0821.05
Price/Book Value
5.571.362.05
Price/Sales
3.105.736.16
Price/Cash Flow
27.0817.6114.42
Price/Earnings
BRKR
301122
688468

Financial Strength

Metric
BRKR
301122
688468
Quick Ratio
0.669.534.71
Current Ratio
1.6511.595.48
Interest Coverage
16.277,815.76111.54
Quick Ratio
BRKR
301122
688468

Profitability

Metric
BRKR
301122
688468
Return on Assets (Normalized)
8.17%3.62%7.46%
Return on Equity (Normalized)
25.98%3.85%9.59%
Return on Invested Capital (Normalized)
12.78%3.66%7.98%
Return on Assets
BRKR
301122
688468

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
JmfyzdtgQlglkg$195.3 Bil
Stryker Corp
SYK
ZyhzxvglrJzlm$134.0 Bil
Boston Scientific Corp
BSX
WlprpbqlPvrzhr$123.4 Bil
Medtronic PLC
MDT
MptbbzqRbkkd$112.6 Bil
Edwards Lifesciences Corp
EW
XknpmqzqhqVtvpgw$39.4 Bil
Koninklijke Philips NV ADR
PHG
NqgqYfrc$30.1 Bil
DexCom Inc
DXCM
WcfwczyhqBrfww$26.3 Bil
Steris PLC
STE
ZbgkdrgfnPmvbkck$23.0 Bil
Zimmer Biomet Holdings Inc
ZBH
FnwbhdnzzZmcgb$21.2 Bil
Insulet Corp
PODD
ZkvvkbrkrjQmmxzk$16.1 Bil

Sponsor Center